Xconomy National

Archives

by in

Entry	Author	Date	Location
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board	Arlene Weintraub	02/09/12	Boston
Brightcove, Radius, Synchroneuron, & More Boston-Area Dealmakers	Erin Kutz	02/08/12	Boston
Radius Health Seeks $86M IPO	Arlene Weintraub	02/07/12	Boston
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M	Bruce V. Bigelow	02/07/12	San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
Dendreon Names John Johnson CEO After Volatile Year	Arlene Weintraub	02/01/12	Seattle
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics	Luke Timmerman	02/01/12	San Francisco
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says	Luke Timmerman	02/01/12	Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News	Erin Kutz	02/01/12	Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug	Luke Timmerman	01/31/12	Boston
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic	Luke Timmerman	01/31/12	San Diego
Four Themes to Watch in Personalized Medicine	Jonathan Sheffi	01/30/12	San Francisco
Gates, 13 Pharmas Join $785M Push for Neglected Diseases	Luke Timmerman	01/30/12	Seattle
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis	Arlene Weintraub	01/30/12	Boston
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
Never Back Smug: A Lesson for Life Sciences From Newt Gingrich	Luke Timmerman	01/30/12	National
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
2012 Venture Outlook: Some Bright Spots and Some Gloom	Bruce V. Bigelow	01/27/12	National
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation	Luke Timmerman	01/27/12	Seattle
Why Biogen Idec Got Out of the Corporate VC Business	Luke Timmerman	01/27/12	Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
Verastem Bucks the Trend, Raises $55M in IPO	Luke Timmerman	01/26/12	Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere	Luke Timmerman	01/26/12	Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event	Arlene Weintraub	01/26/12	Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs	Arlene Weintraub	01/26/12	Boston
Theraclone, VLST Founders Form New Antibody Startup, V-Gene	Luke Timmerman	01/26/12	Seattle
Roche Makes $5.7B Hostile Takeover Bid for Illumina	Luke Timmerman	01/25/12	San Diego
Family Affair: Courtagen Applies Management DNA to Genomics Startup	Arlene Weintraub	01/25/12	Boston
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly	Luke Timmerman	01/25/12	San Francisco
Page 1 of 159	next page »